1、 ChinaAMC Leveraged/Inverse Series ChinaAMC NASDAQ-100 Index Daily(2x)Leveraged Product ChinaAMC NASDAQ-100 Index Daily(-2x)Inverse Product Annual Report For the year ended 31 December 2024 ANNUAL REPORT CHINAAMC NASDAQ-100 INDEX DAILY(2x)LEVERAGED PRODUCT(Stock Code:7261)CHINAAMC NASDAQ-100 INDEX D
2、AILY(-2x)INVERSE PRODUCT (Stock Code:7522)FOR THE YEAR ENDED 31 DECEMBER 2024 (PRODUCTS OF CHINAAMC LEVERAGED/INVERSE SERIES)CHINAAMC LEVERAGED/INVERSE SERIES CONTENTS Pages MANAGEMENT AND ADMINISTRATION 1 2 REPORT OF THE MANAGER TO THE UNITHOLDERS 3 6 REPORT OF THE TRUSTEE TO THE UNITHOLDERS 7 STAT
3、EMENT OF RESPONSIBILITIES OF THE MANAGER AND THE TRUSTEE 8 INDEPENDENT AUDITORS REPORT 9 14 AUDITED FINANCIAL STATEMENTS Statements of financial position 15 Statements of profit or loss and other comprehensive income 16 Statements of changes in net assets attributable to unitholders 17 Statements of
4、 cash flows 18 19 Notes to the financial statements 20 53 INVESTMENT PORTFOLIO(UNAUDITED)54 MOVEMENTS IN INVESTMENT PORTFOLIO(UNAUDITED)55 DETAILS IN RESPECT OF FINANCIAL DERIVATIVE INSTRUMENTS(UNAUDITED)56 INFORMATION ON EXPOSURE ARISING FROM FINANCIAL DERIVATIVE INSTRUMENTS(UNAUDITED)57 58 PERFORM
5、ANCE RECORD(UNAUDITED)59 IMPORTANT:Any opinion expressed herein reflects the Managers view only and is subject to change.For more information about the Products of the ChinaAMC Leveraged/Inverse Series,please refer to the prospectus of the ChinaAMC Leveraged/Inverse Series which is available at our
6、website:http:/.hk/en/products.html?linkage_id=990351 Investors should not rely on the information contained in this report for their investment decisions.1 CHINAAMC LEVERAGED/INVERSE SERIES MANAGEMENT AND ADMINISTRATION Manager China Asset Management(Hong Kong)Limited 37/F,Bank of China Tower 1 Gard